{"schemaVersion":"maha-epistemic/1.0","evidencePolicyVersion":"mps/0.1","recordId":"urn:maha:record:biomolecular-engineering-cell-free-transcription-translation","canonicalPath":"/knowledge/biomolecular-engineering/concepts/biomolecular-engineering-cell-free-transcription-translation","contentHash":"sha256:83ac985a6239c41fa9b53a3c64b53e64806d9bf83f439eba51ee774124bbcd77","generatedAt":"2026-08-27T04:26:28.206Z","publicationDecision":{"recordId":"urn:maha:record:biomolecular-engineering-cell-free-transcription-translation","publicEligible":true,"evaluatedAgainst":"maha-epistemic/1.0","reasons":[]},"claims":[{"id":"urn:maha:claim:biomolecular-engineering-cell-free-transcription-translation","scope":"Limited to Cell-free platform, protein engineering, metabolic engineering, artificial-cell engineering, and conclusions sections. in “Cell-free synthetic biology: Engineering in an open world”; this candidate records the concept boundary and does not pool results from uncited systems or studies.","boundary":"Cell free transcription translation does not by itself establish system-level performance, safety, manufacturability, scalability, economic advantage, clinical benefit, or deployment readiness.","claimKind":"theoretical-model","sourceIds":["source-biomolecular-engineering-cell-free"],"statement":"The cited source supports treating cell free transcription translation as a distinct concept within the stated biomolecular engineering scope.","replication":{"asOfDate":"2026-08-24","assessment":"Independent replication and cross-platform transfer have not been compiled for this candidate; the evidence maturity refers only to the bounded source contract.","independentReplicationCount":null},"uncertainty":{"kind":"qualitative","statement":"No cross-source quantitative interval is asserted. Definitions, operating conditions, samples, instruments, and outcome measures must be checked against the exact cited locator during review."},"evidenceMaturity":"single-study"}],"sources":[{"id":"source-biomolecular-engineering-cell-free","url":"https://doi.org/10.1016/j.synbio.2017.02.003","title":"Cell-free synthetic biology: Engineering in an open world","rights":{"note":"The candidate uses original boundary language and a short paraphrase linked to the cited source. No source passage, figure, or table is reproduced.","basis":"citation-with-paraphrase","quotationUsed":false},"authors":["Yuan Lu"],"boundary":"In-vitro expression yield does not establish cellular, organismal, manufacturing, or clinical performance.","publisher":"Synthetic and Systems Biotechnology","establishes":"The review describes cell-free synthetic-biology platforms and engineering variables exposed outside intact cells.","identifiers":[{"value":"10.1016/j.synbio.2017.02.003","scheme":"doi"}],"publishedAt":"2017-03-01","exactLocator":"Cell-free platform, protein engineering, metabolic engineering, artificial-cell engineering, and conclusions sections."}],"reviewEvents":[{"scope":"source-fidelity","verdict":"approve","reviewId":"epireview_cfc67798bbdc452396ecdb8473777837","rationale":"Lu’s open-access review directly covers cell-free protein synthesis plus protein, metabolic, and artificial-cell engineering. The record limits itself to engineering outside living cells and does not convert a review into a new experimental result. This approval is limited to source-fidelity, record urn:maha:record:biomolecular-engineering-cell-free-transcription-translation, and exact target sha256:fab0b69c3399c2fc046edf1f5c653a02ddee5445dceb8f9976babc948d1b4547; it is internal editorial review rather than external expert endorsement.","reviewedAt":"2026-08-27T04:26:20.050Z","reviewerId":"expert_maha-internal-editorial-v2","reviewMethod":"Record-specific exact-revision review against the inspected source location, bounded claim, non-claims, rights basis, and source identity. No external reviewer participated.","reviewerKind":"internal-editorial","reviewerRole":"AI-assisted internal source, scope, boundary, rights, and locator review. This is an organizational editorial method, not an external subject-matter credential.","targetSha256":"sha256:fab0b69c3399c2fc046edf1f5c653a02ddee5445dceb8f9976babc948d1b4547","supersedesReviewId":null,"reviewerProfileVersion":2},{"scope":"domain-fidelity","verdict":"approve","reviewId":"epireview_53e6c7a530c64fdbb8bdbc5c535ce922","rationale":"The terminology and mechanism stay within cell-free transcription/translation and synthetic-biology platforms; no in-vivo efficacy, clinical transfer, or organism-level behavior is inferred. This approval is limited to domain-fidelity, record urn:maha:record:biomolecular-engineering-cell-free-transcription-translation, and exact target sha256:fab0b69c3399c2fc046edf1f5c653a02ddee5445dceb8f9976babc948d1b4547; it is internal editorial review rather than external expert endorsement.","reviewedAt":"2026-08-27T04:26:20.261Z","reviewerId":"expert_maha-internal-editorial-v2","reviewMethod":"Record-specific exact-revision review against the inspected source location, bounded claim, non-claims, rights basis, and source identity. No external reviewer participated.","reviewerKind":"internal-editorial","reviewerRole":"AI-assisted internal source, scope, boundary, rights, and locator review. This is an organizational editorial method, not an external subject-matter credential.","targetSha256":"sha256:fab0b69c3399c2fc046edf1f5c653a02ddee5445dceb8f9976babc948d1b4547","supersedesReviewId":null,"reviewerProfileVersion":2},{"scope":"boundary-adequacy","verdict":"approve","reviewId":"epireview_d20029b258834454a8ec3d5a87ee94b5","rationale":"The record preserves single-source maturity, absent pooled intervals and absent independent reproduction, while prohibiting safety, scale, manufacturability, economics, and clinical-benefit conclusions. This approval is limited to boundary-adequacy, record urn:maha:record:biomolecular-engineering-cell-free-transcription-translation, and exact target sha256:fab0b69c3399c2fc046edf1f5c653a02ddee5445dceb8f9976babc948d1b4547; it is internal editorial review rather than external expert endorsement.","reviewedAt":"2026-08-27T04:26:20.411Z","reviewerId":"expert_maha-internal-editorial-v2","reviewMethod":"Record-specific exact-revision review against the inspected source location, bounded claim, non-claims, rights basis, and source identity. No external reviewer participated.","reviewerKind":"internal-editorial","reviewerRole":"AI-assisted internal source, scope, boundary, rights, and locator review. This is an organizational editorial method, not an external subject-matter credential.","targetSha256":"sha256:fab0b69c3399c2fc046edf1f5c653a02ddee5445dceb8f9976babc948d1b4547","supersedesReviewId":null,"reviewerProfileVersion":2},{"scope":"rights-and-locator","verdict":"approve","reviewId":"epireview_131c1d23069a4d90929488487e62ad51","rationale":"The source is DOI 10.1016/j.synbio.2017.02.003 at the open-access abstract and protein-, metabolic-, and artificial-cell-engineering sections. Citation and paraphrase are retained without copied source text or figures. This approval is limited to rights-and-locator, record urn:maha:record:biomolecular-engineering-cell-free-transcription-translation, and exact target sha256:fab0b69c3399c2fc046edf1f5c653a02ddee5445dceb8f9976babc948d1b4547; it is internal editorial review rather than external expert endorsement.","reviewedAt":"2026-08-27T04:26:20.567Z","reviewerId":"expert_maha-internal-editorial-v2","reviewMethod":"Record-specific exact-revision review against the inspected source location, bounded claim, non-claims, rights basis, and source identity. No external reviewer participated.","reviewerKind":"internal-editorial","reviewerRole":"AI-assisted internal source, scope, boundary, rights, and locator review. This is an organizational editorial method, not an external subject-matter credential.","targetSha256":"sha256:fab0b69c3399c2fc046edf1f5c653a02ddee5445dceb8f9976babc948d1b4547","supersedesReviewId":null,"reviewerProfileVersion":2}]}